Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 May 2024
Information, analysis, and features on topics connected to cancer.
Read Full NewsClinicians continue prescribing antibiotics unnecessarily despite growing evidence supporting shorter, targeted, and reassessed treatment strategies.
Nearly 300 experts warn that rising vaccine misinformation is reversing gains — measles and meningococcal infections are resurging while France updates the 2026 schedule.
Patients were randomly assigned 1:1 to receive either concurrent radiation dose escalation to the lumpectomy cavity during whole-breast irradiation or sequential boost after whole-breast irradiation.
The agency OK’d trastuzumab deruxtecan for two indications in HER2-positive early-stage breast cancer, covering both the neoadjuvant and adjuvant settings.
1.
France Expands 2026 Vaccination Rules Amid Resurgence
2.
AI-based breast cancer risk technology receives FDA breakthrough device designation
3.
Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study
4.
PSA Often Unchanged With Enzalutamide Progression
5.
Can taking vitamin D supplements every day lower the mortality rate from cancer?
1.
Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection
2.
How to Manage Dic with the Right Treatment Approach
3.
Future-Ready Cancer Screening: What Every Clinician Should Know in 2025
4.
Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor
5.
Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
2.
Oropharyngeal Cancer in Relation to HPV Status
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge